ARTICLE | Company News
Siga infectious news
May 16, 2011 7:00 AM UTC
HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded Siga Technologies a contract for its ST-246 smallpox antiviral worth up to $2.8 billion. The contract comprises an initial...